Biogen Multiple Sclerosis Pregnancy Exposure Registry

计划入组 408 人 · 首次发布于 2013 年 7 月 30 日

A Healthy Volunteer Study to Establish the Bioequivalence of BG00012 Supplied by 2 Different Commercial Manufacturers

计划入组 80 人 · 首次发布于 2014 年 6 月 24 日

Comparative Clinical Trial to Evaluate Efficacy, Safety and Tolerance of BCD-054 and Avonex® for Treatment of Patients With Remitting-relapsing Multiple Sclerosis

计划入组 399 人 · 首次发布于 2016 年 4 月 20 日

Briobacept

Interferon beta gene therapy (Biogen Idec/Targeted Genetics)

retinoid-acid receptor-related orphan receptor gamma gamma inverse agonists (Biogen)

Biogen Idec Ltd.

United Kingdom

Biogen Idec Inc

United States

BIOGEN IDEC LIMITED

United Kingdom

GlycoEra Appoints Petra Duda as Chief Medical Officer to Lead Precision Protein Degrader Pipeline

BioCryst Pharmaceuticals Appoints Sandeep M. Menon as Chief Research and Development Officer

TOLREMO Therapeutics Strengthens Leadership with Key Appointments as TT125-802 Shows Clinical Promise